These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20085495)

  • 1. In vivo parasitological measures of artemisinin susceptibility.
    Stepniewska K; Ashley E; Lee SJ; Anstey N; Barnes KI; Binh TQ; D'Alessandro U; Day NP; de Vries PJ; Dorsey G; Guthmann JP; Mayxay M; Newton PN; Olliaro P; Osorio L; Price RN; Rowland M; Smithuis F; Taylor WR; Nosten F; White NJ
    J Infect Dis; 2010 Feb; 201(4):570-9. PubMed ID: 20085495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013.
    Liu H; Yang HL; Tang LH; Li XL; Huang F; Wang JZ; Li CF; Wang HY; Nie RH; Guo XR; Lin YX; Li M; Wang J; Xu JW
    Malar J; 2015 Feb; 14():47. PubMed ID: 25652213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
    ; Abdulla S; Ashley EA; Bassat Q; Bethell D; Björkman A; Borrmann S; D'Alessandro U; Dahal P; Day NP; Diakite M; Djimde AA; Dondorp AM; Duong S; Edstein MD; Fairhurst RM; Faiz MA; Falade C; Flegg JA; Fogg C; Gonzalez R; Greenwood B; Guérin PJ; Guthmann JP; Hamed K; Hien TT; Htut Y; Juma E; Lim P; Mårtensson A; Mayxay M; Mokuolu OA; Moreira C; Newton P; Noedl H; Nosten F; Ogutu BR; Onyamboko MA; Owusu-Agyei S; Phyo AP; Premji Z; Price RN; Pukrittayakamee S; Ramharter M; Sagara I; Se Y; Suon S; Stepniewska K; Ward SA; White NJ; Winstanley PA
    Malar J; 2015 Sep; 14():359. PubMed ID: 26390866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment.
    Wilairat P; Kümpornsin K; Chookajorn T
    Med Hypotheses; 2016 May; 90():19-22. PubMed ID: 27063079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine.
    Song J; Socheat D; Tan B; Dara P; Deng C; Sokunthea S; Seila S; Ou F; Jian H; Li G
    Malar J; 2010 Feb; 9():57. PubMed ID: 20175930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity.
    Stepniewska K; Price RN; Sutherland CJ; Drakeley CJ; von Seidlein L; Nosten F; White NJ
    Malar J; 2008 Dec; 7():249. PubMed ID: 19055751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
    Osorio L; Gonzalez I; Olliaro P; Taylor WR
    Malar J; 2007 Feb; 6():25. PubMed ID: 17328806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
    Fukuda N; Balikagala B; Ueno T; Anywar DA; Kimura E; Palacpac NMQ; Odongo-Aginya EI; Ogwang M; Horii T; Miida T; Mita T
    Clin Infect Dis; 2023 May; 76(9):1585-1593. PubMed ID: 36519341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
    Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
    Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
    Ndour PA; Lopera-Mesa TM; Diakité SA; Chiang S; Mouri O; Roussel C; Jauréguiberry S; Biligui S; Kendjo E; Claessens A; Ciceron L; Mazier D; Thellier M; Diakité M; Fairhurst RM; Buffet PA
    J Infect Dis; 2015 Jan; 211(2):290-7. PubMed ID: 25183768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives.
    Flegg JA; Guérin PJ; Nosten F; Ashley EA; Phyo AP; Dondorp AM; Fairhurst RM; Socheat D; Borrmann S; Björkman A; Mårtensson A; Mayxay M; Newton PN; Bethell D; Se Y; Noedl H; Diakite M; Djimde AA; Hien TT; White NJ; Stepniewska K
    Malar J; 2013 Nov; 12():411. PubMed ID: 24225303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
    Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
    Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.
    Huang F; Takala-Harrison S; Jacob CG; Liu H; Sun X; Yang H; Nyunt MM; Adams M; Zhou S; Xia Z; Ringwald P; Bustos MD; Tang L; Plowe CV
    J Infect Dis; 2015 Nov; 212(10):1629-35. PubMed ID: 25910630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin resistance in Plasmodium falciparum: what is it really?
    Ferreira PE; Culleton R; Gil JP; Meshnick SR
    Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies.
    Gbotosho GO; Sowunmi A; Happi CT; Okuboyejo TM
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):685-90. PubMed ID: 22012222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
    Bousema T; Okell L; Shekalaghe S; Griffin JT; Omar S; Sawa P; Sutherland C; Sauerwein R; Ghani AC; Drakeley C
    Malar J; 2010 May; 9():136. PubMed ID: 20497536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
    Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
    Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.